Page last updated: 2024-08-25

5-iminodaunorubicin and protocatechuic acid

5-iminodaunorubicin has been researched along with protocatechuic acid in 1 studies

*protocatechuic acid: RN given refers to parent cpd; structure [MeSH]

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
De Graff, WG; Hahn, SM; Mitchell, JB; Myers, LS	1

Other Studies

1 other study(ies) available for 5-iminodaunorubicin and protocatechuic acid

Article	Year
Protection against Adriamycin cytotoxicity and inhibition of DNA topoisomerase II activity by 3,4-dihydroxybenzoic acid. International journal of oncology, 2003, Volume: 23, Issue:1 Topics: Animals; Antibiotics, Antineoplastic; Anticarcinogenic Agents; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Daunorubicin; DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Doxorubicin; Electrophoresis, Agar Gel; Free Radicals; Hydroxybenzoates; Oxidation-Reduction; Topoisomerase II Inhibitors	2003

Article

Year

Protection against Adriamycin cytotoxicity and inhibition of DNA topoisomerase II activity by 3,4-dihydroxybenzoic acid.

International journal of oncology, 2003, Volume: 23, Issue:1

Topics: Animals; Antibiotics, Antineoplastic; Anticarcinogenic Agents; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Daunorubicin; DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Doxorubicin; Electrophoresis, Agar Gel; Free Radicals; Hydroxybenzoates; Oxidation-Reduction; Topoisomerase II Inhibitors

2003